Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Cap-xx Limited LSE:CPX London Ordinary Share AU0000XINAS1 ORD NPV
  Price Change % Change Share Price Shares Traded Last Trade
  0.10 1.05% 9.60 1,181,394 14:47:58
Bid Price Offer Price High Price Low Price Open Price
9.20 10.00 9.75 9.26 9.75
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic & Electrical Equipment 2.00 -2.73 -0.72 42
Last Trade Time Trade Type Trade Size Trade Price Currency
17:09:00 O 100,000 9.64 GBX

Cap-xx (CPX) Latest News

More Cap-xx News
Cap-xx Investors    Cap-xx Takeover Rumours

Cap-xx (CPX) Discussions and Chat

Cap-xx Forums and Chat

Date Time Title Posts
22/1/202115:27CAP-XX Supercapacitors - Power to the IoT6,576
24/12/202014:27cpx no censorship here, speak your mind.2,269
11/7/201909:13CAP-XX limited - 2018 and beyond with Apple29
01/4/201912:49CAPP - XX plc10
28/3/201907:29CPX Short thread63

Add a New Thread

Cap-xx (CPX) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-01-22 17:15:009.65250,00024,125.00O
2021-01-22 17:15:009.67250,00024,165.00O
2021-01-22 17:09:009.6053,0005,088.00O
2021-01-22 16:27:599.6310,000962.50O
2021-01-22 16:20:519.635,194499.92O
View all Cap-xx trades in real-time

Cap-xx (CPX) Top Chat Posts

DateSubject
22/1/2021
08:20
Cap-xx Daily Update: Cap-xx Limited is listed in the Electronic & Electrical Equipment sector of the London Stock Exchange with ticker CPX. The last closing price for Cap-xx was 9.50p.
Cap-xx Limited has a 4 week average price of 9.25p and a 12 week average price of 4p.
The 1 year high share price is 14.25p while the 1 year low share price is currently 1.80p.
There are currently 442,115,811 shares in issue and the average daily traded volume is 1,851,126 shares. The market capitalisation of Cap-xx Limited is £42,443,117.86.
21/1/2021
16:14
celeritas: Now if CPX came out with something like this from ika. The Board notes the recent rise in the Company's share price and the growing interest in solid state batteries in the media in recent weeks regarding their future potential in automotive applications. The Company reiterates its guidance set out in the announcements dated 11 and 24 November 2020. In particular, whilst the Board is confident about the prospects for the Company's Goliath larger format batteries, mass market commercialisation is dependent on further technical development and successful manufacturing scale-up.
07/1/2021
20:07
drobinson1991: Yeah I agree, I think some are jumping ahead of themselves. Money was raised to pay for the equipment from Japan that was purchased at the huge discount! Production is up and running and that's that! No mention of anything to do with buying even more equipment yet so nothing to worry about. No mention of further cash raising, its all BS from people who are probably trading this to grab a quick buck. Long term prospects are still the same and the court case is moving along. The price decline is expected as news slows down, like mentioned, a share price doesn't always go up. I'm in this for the long run as the prospects remain the same. Any dips I will keep buying to top up. Do you own research guys and ignore speculation. Worth checking out Allenby capital for research docs
07/1/2021
17:36
meijiman: Yes but much has changed here post the Murata deal. Cpx is now on the cusp of making profits and generating cash. This should put a decent floor into the share price.
20/12/2020
13:14
bomber13: The recent buoyancy of the CAP-XX shareprice is certainly one very positive development ahead of its half-year end this month , but what really caught my eye was the announcement on 10th December that all remaining 14.7m options from the 2015 incentive scheme , which were due to expire forthwith , would be exercised at 5p per share by directors and senior employees , thereby raising a not insignificant £734/- for the company . About 90% of this amount will be subscribed for by just seven of the company's principals with the lion's share of £300/- attributed to Anthony Kongats , the founder and CEO . Under normal circumstances one would have expected a contiguous placing with institutions to facilitate payment , but , despite the new shares having been admitted to trading last Tuesday ( 15th December ) , there has been none . Which begs the obvious question of whether forthcoming newsflow has placed a restriction on share trading by the company's principals or not ? Newsflow could indeed come from any number of fronts . CAP-XX reported further progress at its 25th November AGM with regard to its pursuit of various licencing and patent infringement cases , but could not go into detail . Its most significant outstanding infringement case , with Maxwell/Tesla , is going to mediation , and , if this is where progress is being made , ie potential out of court settlement and ongoing licence deal , that would indeed be game-changing . CAP-XX also reported an ever stronger order book at the AGM , high levels of enquiry for product from their new X- Murata plant , and their first expected shipments this month from it . Will we get a trading update either pre or post the half-year end of 31st December ? Will we also hear that CAP-XX has received its A$3.2m R&D tax rebate , which is expected and due ? Whatever newsflow comes our way , it is nevertheless reassuring to look at what the options exercise will do to the CEO and founder's shareholding pro tem . At flotation in April 2006 CAP-XX was valued by the stock market at £45m on a shareprice of 93p , and Anthony Kongats held around 10.3% . Since then , despite participating in at least 2 fundraisings , and without selling one share , his percentage holding has been diluted to only 2.3% by end June 2020 . However , post the option exercise his holding will have risen to 3.7% of a current market cap of £38m at 8.3p . His two fellow NED's , aged 68 and 74 , and who have been drawing their salary in shares since 2014 , will own 2% and 1.4% of the equity respectively . There is only one further significant option scheme remaining , which represents around 16.5m shares or 3.6% of the new issued equity , and these are exercisable at 11.5p per share with an expiry date of 11th December , 2022 . The CEO accounts for about a quarter of these options . The CAP-XX shareprice is telling us good news is on the way , and the take up of options without a placing is certainly adding to that anticipation .
10/12/2020
15:58
charker: If the future is rosey why would they sell large quantities? 2m shares each is £150k each at today's prices, A share price of 50p (achievable in short order according to some) would see them all millionaires. If they bale, when they don't have their own hard-earned riding on this, it will be sending a very negative message. I guess they may sell a few to cover some of the purchase price. Are they options or free shares? If options I guess they have to find the 2m x 5p.
10/12/2020
13:12
klosters65: Seven persons, managing/working/advising CPX are to receive over 14.5 million shares, which are to be admitted for trading 15th December. Question – how many of these shares,what percentage might you expect to be sold on the 15th or shortly after. Might there be a buyer lined up for some of the shares, which would presumably stop the share prices going down.
07/12/2020
10:32
roofer2: CPX new production line as already at full capacity, new license deals in the pipeline that includes Tesla Maxwell litigation ! I can’t honestly see what could possibly stop CPX from being many multiple times current share price ! Imo R2
26/11/2020
11:28
roofer2: Tesla/Maxwell share price valued at around $544 billion, who much will the share price fall due to IP infringement, a dam sight more than the $240 million paid for Maxwell that’s for sure, a take over if CPX is a no brainer and that’s not including the worldwide manufacturing distribution that’s at near 100% capacity! Imo R2
27/10/2020
11:40
euclid5: Positive trading update on multiple fronts. As previously argued, the acquisition of the Murata manufacturing assets represents a transformational deal for CPX. It afforded a unique opportunity to transform its profitability by increasing sales and gross margin at the product level for a minimal capital outlay and enable CPX to fulfil the growing levels of sales enquiries. The deal provides access to established product designs, proven manufacturing assets and a potential customer base in CPX's target small form factor markets. The project is not without execution risk, however, and CPX has not been immune to the impact of CV-19 with the project slipping by c. three months. The successful prosecution of the Ioxus patent infringement case represents an important proof point in CPX's ongoing IP protection strategy. Finally, the growth in the sales order book and revenue in Q1 is encouraging as more companies look to supercapacitors to address the limitations of traditional batteries. hxxp://www.allenbycapital.com/research/research-cpx_37_418843376.pdf
14/10/2020
12:29
meijiman: Great post and well thought through. It was becoming apparent that the licencing out/ Royalty model was not going to move the dial. Seems like there are very few companies who can get this to work properly most notably ARM. Still don't suppose cpx reckoned on the amount of patent infringement that happened. I'm very hopeful of another win on the Maxwell front. Whilst cpx had something that was new and technically excellent the world was not QUITE ready. Think that is now starting to change which suggests the share price has plenty of upside.
Cap-xx share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
CPX
Cap-xx
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210123 03:03:19